Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
23.64
-1.28 (-5.14%)
At close: Jul 6, 2026, 4:00 PM EDT
23.66
+0.02 (0.08%)
After-hours: Jul 6, 2026, 4:04 PM EDT
Surrozen Employees
Surrozen had 44 employees as of December 31, 2025. The number of employees increased by 3 or 7.32% compared to the previous year.
Employees
44
Change (1Y)
3
Growth (1Y)
7.32%
Revenue / Employee
$170,318
Profits / Employee
-$7,785,477
Market Cap
274.70M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 44 | 3 | 7.32% | 44 | 0 |
| Dec 31, 2024 | 41 | -1 | -2.38% | 40 | 1 |
| Dec 31, 2023 | 42 | -32 | -43.24% | 42 | 0 |
| Dec 31, 2022 | 74 | -9 | -10.84% | 74 | 0 |
| Dec 31, 2021 | 83 | - | - | 83 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Bicycle Therapeutics | 288 |
| Entrada Therapeutics | 152 |
| Adagene | 128 |
| Niagen Bioscience | 117 |
| Neumora Therapeutics | 92 |
| SAB Biotherapeutics | 86 |
| ALX Oncology Holdings | 43 |
SRZN News
- 6 weeks ago - Surrozen Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 7 weeks ago - Surrozen Transcript: AGM 2026 - Transcripts
- 7 weeks ago - Surrozen to Present at Upcoming Healthcare Investor Conference - GlobeNewsWire
- 2 months ago - Surrozen price target raised to $44 from $36 at H.C. Wainwright - TheFly
- 2 months ago - Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year - TheFly
- 2 months ago - Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Surrozen Earnings release: Q1 2026 - Filings
- 2 months ago - Surrozen Quarterly report: Q1 2026 - Filings